Versant Capital Management’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$7.15K Hold
540
– – ﹤0.01% 2370
2026
Q2
$5.98K Buy
+540
New +$3.3K ﹤0.01% 2396
2025
Q3
– Sell
-288
Closed -$2.68K – 2706
2025
Q2
$2.68K Hold
288
– – ﹤0.01% 2329
2025
Q1
$2.81K Hold
288
– – ﹤0.01% 2216
2024
Q4
$3.49K Buy
288
+165
+134% +$2K ﹤0.01% 1925
2024
Q3
$1.35K Buy
+123
New +$1.25K ﹤0.01% 1676
2024
Q2
– Sell
-94
Closed -$768 – 1995
2024
Q1
$768 Buy
+94
New +$771 ﹤0.01% 1597
2023
Q4
– Sell
-25
Closed -$428 – 1994
2023
Q3
$428 Sell
25
-3
-11% -$59 ﹤0.01% 1724
2023
Q2
$650 Buy
+28
New +$547 ﹤0.01% 1748

Other funds holding REPL

Versant Capital Management's REPL Position: Q3 2026 in Review

Versant Capital Management held its Replimune Group (REPL) position steady in Q3 2026 at 540 shares worth $7.15K. The position accounts for ﹤0.01% of the portfolio, ranked #2370.

Versant Capital Management first reported a position in REPL in Q2 2023 and has held it in 9 quarters since. 18 funds tracked by Wall St. Rank hold REPL as of Q3 2026.

  • Versant Capital Management held 540 shares of Replimune Group worth $7.15K as of Q3 2026.
  • Versant Capital Management left its Replimune Group share count unchanged in Q3 2026.
  • Replimune Group made up ﹤0.01% of Versant Capital Management's portfolio in Q3 2026, its #2370 holding.
  • Versant Capital Management first reported a position in Replimune Group in Q2 2023 and has held it in 9 quarters since.
  • 18 funds tracked by Wall St. Rank held Replimune Group as of Q3 2026.

Based on Versant Capital Management's 13F filing for Q3 2026, filed 2 Oct 2026.